If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.60    0.02 (0.74%)
Bid:
2.60
Ask:
2.82
Spread: 0.22 (8.462%)
Market Cap: £4.74m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Trading Update

16 Aug 2022 07:00

RNS Number : 0970W
Nanoco Group PLC
16 August 2022
 

16 August 2022

 

NANOCO GROUP PLC

("Nanoco", the "Company" or the "Group")

 

Year End Trading Update

 

Notice of Results

 

"Positive organic momentum and extended cash runway ahead of Samsung trial"

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, today provides the following year end trading update ahead of the announcement of its final results for the year to 31 July 2022, which will be released in October 2022.

Financial highlights:

· Unaudited revenues of £2.4m for the year ended 31 July 2022, in line with the Board's expectations and just over 10% above FY21.

· Continued proactive management of the cost base resulting in a reduced Adjusted LBITDA, slightly ahead of the Board's expectations.

· Unaudited cash position at 31 July 2022 of £6.8m, an increase of £5.0m since 31 January 2022, reflecting the over-subscribed £5.4m equity raise (net) in June 2022 and good operating cash performance in H2 FY22.

· Cash runway extended to calendar year 2025, beyond the expected point at which the Group's organic operations become self-financing.

 

Operational highlights

· Major work package (the fifth) for European electronics customer signed in June 2022, further underpinning the Group's cash runway.

· Additional development work and material supplies continue for the major Asian chemical company.

· Group order book more than doubled year-on-year.

· Ongoing consolidation of the Group's operations in to one facility in Runcorn.

Litigation update

· As previously announced, trial set to start 12 September 2022 and expected to last one week.

· Pre-trial conference date has been set for 18-19 August 2022.

· Judge issued ruling rejecting Samsung motion to change the definitions of an important technical term in the case (previously decided in Nanoco's favour at the Markman hearing).

Final results date

The Company expects to announce its final results for the year ended 31 July 2022 in the second half of October 2022.

 

 

Brian Tenner, Chief Executive of Nanoco, said:

"The Group delivered two very important milestones in the second half of FY22. We emphatically won all five patents and all 47 claims that were contested by Samsung at the Patent Trial and Appeal Board. We also delivered a significant contract extension with our European electronics customer that covers the work required to scale up and validate our nano-materials for production readiness.

 

"We move forward with confidence to the scheduled trial in the IP litigation on 12 September 2022 and to validating our products in H1 of FY23, ahead of expected visibility of production orders shortly thereafter. We are completing the relocation of our Manchester operations into the consolidated site in Runcorn to deliver operational benefits and real cash savings.

 

"The combination of strong progress on the IP litigation and the underlying organic business is a robust platform to deliver significant value to all of our stakeholders in the short to medium term."

 

- Ends -

For further information, please contact:

Nanoco Group PLC:

Brian Tenner, CEO +44 (0) 161 603 7900

Liam Gray, CFO & Company Secretary +44 (0) 161 603 7900

 

Peel Hunt (Joint Corporate Broker):

Edward Knight +44 (0) 20 7418 8900

James Smith

 

Turner Pope Investments (Joint Corporate Broker):

Andrew Thacker +44 (0) 20 3657 0050

James Pope

 

MHP Communications: +44 (0) 203 128 8570

Reg Hoare

Pete Lambie

nanoco@mhpc.com

 

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots and other nano-materials. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display, Sensor and Electronics markets. An interesting property of quantum dots is their absorption spectrum. Nanoco's HEATWAVE™ quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectrum, rendering them useful for applications including image sensors. Another interesting property of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPAMBTMTJBTBT
Date   Source Headline
7th Nov 201912:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group Plc
6th Nov 20195:32 pmRNSForm 8.3 - [Nanoco Group]
6th Nov 20193:20 pmRNSForm 8.3 - Nanoco Group PLC
6th Nov 201912:00 pmRNSForm 8.5 (EPT/RI) - Nanoco Group PLC
5th Nov 20193:36 pmPRNForm 8 (OPD) Nanoco Group Plc
5th Nov 20199:03 amRNSForm 8.3 - Nanaco Group PLC
5th Nov 20197:00 amRNSFormal Sale Process as Part of Strategic Review
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
1st Nov 20197:00 amRNSAnnual Report and Notice of AGM
31st Oct 201910:44 amRNSTotal Voting Rights and Share Capital
23rd Oct 201911:40 amRNSHolding(s) in Company
18th Oct 20194:35 pmRNSHolding(s) in Company
16th Oct 20197:00 amRNSPreliminary Results
10th Oct 20199:40 amRNSHolding(s) in Company
23rd Sep 20193:03 pmRNSHolding(s) in Company
23rd Sep 20193:02 pmRNSHolding(s) in Company
6th Sep 20194:35 pmRNSPrice Monitoring Extension
5th Sep 20194:35 pmRNSPrice Monitoring Extension
4th Sep 20191:00 pmRNSNotice of Results
22nd Aug 20192:00 pmRNSHolding(s) in Company
15th Aug 20197:00 amRNSYear End Trading Update and Notice of Results
1st Aug 20196:15 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSContract Liability Waived
3rd Jul 20195:50 pmRNSHolding(s) in Company
27th Jun 201912:15 pmRNSHolding(s) in Company
26th Jun 20193:20 pmRNSDirector/PDMR Shareholding
26th Jun 201911:45 amRNSHolding(s) in Company
25th Jun 201912:45 pmRNSHolding(s) in Company
24th Jun 20193:45 pmRNSHolding(s) in Company
24th Jun 20193:30 pmRNSHolding(s) in Company
24th Jun 20193:30 pmRNSHolding(s) in Company
21st Jun 20197:00 amRNSUS Customer partnership update
12th Jun 201910:25 amRNSBlock listing Interim Review
7th Jun 20194:00 pmRNSDirector/PDMR Shareholding
3rd May 20197:00 amRNSDirector/PDMR Shareholding
2nd May 20196:09 pmRNSDirector/PDMR Shareholding
18th Apr 20194:55 pmRNSDirector/PDMR Shareholding
17th Apr 20193:20 pmRNSHolding(s) in Company
17th Apr 20191:22 pmRNSHolding(s) in Company
16th Apr 20195:08 pmRNSHolding(s) in Company
11th Apr 20193:38 pmRNSHolding(s) in Company
11th Apr 20197:00 amRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSInterim Results
1st Apr 201911:40 amRNSHolding(s) in Company
12th Mar 20197:00 amRNSDirectorate Changes
4th Mar 20197:00 amRNSNotice of Results
31st Jan 20197:00 amRNSChange of Auditor
25th Jan 20197:00 amRNSContract extension signed
4th Jan 201912:18 pmRNSHolding(s) in Company
4th Jan 20197:00 amRNSPartnership with Plessey Semiconductors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.